We conclude that after i.p. injection, nanocarriers containing the carrier IgG as well as the siRNA are transported in vivo through the blood stream to xenografted cells of human origin expressing the CD33 antigen, may this be a subcutaneous tumor or an i.v.-engrafted primary leukemia. The gene discussed is CD33; the disease is leukemia.